OpenAI Foundation Update

The OpenAI Foundation is moving forward with deploying the resources secured through recapitalization to realize AGI that benefits all of humanity. Over the next year, it plans to invest at least $1 billion across life sciences and disease treatment, jobs and economic impact, AI resilience, and community programs.

This represents the initial investment stage of the previously announced $25 billion commitment for disease treatment and AI resilience.

In the life sciences and disease treatment area, the focus is on using AI to accelerate scientific and medical progress, with priority given to the following three key areas:

• Addressing Alzheimer's disease: Accelerating disease pathway mapping, biomarker detection, and personalized treatment.
• Public data in healthcare: Building and expanding high-quality, open datasets for researchers to use.
• High-risk, high-burden disease research: Reducing the cost and risk of developing treatments for underfunded, high-fatality diseases.

This area will be led by Jacob Trefethen, formerly of Coefficient Giving. The foundation will also collaborate with experts including economists and policymakers to prepare practical solutions in response to AI-driven changes in the labor market.